View Full Company Profile

eHealth, Inc.

CIK: 1333493 Filed: February 26, 2026 10-K

Key Highlights

  • Significantly narrowed net loss by 42% in 2024 through disciplined cost management, improving from $60 million to $35 million.
  • Secured a new $100 million revolving credit facility in early 2025, enhancing liquidity and financial flexibility.
  • Strategic focus for 2025 on driving profitable growth, targeting positive adjusted EBITDA and stabilizing Medicare enrollment volumes.
  • Relocated main office to Indianapolis to optimize operational costs and access new talent for technology and customer service initiatives.

Financial Analysis

eHealth, Inc. Annual Report: A Closer Look for Investors

Considering an investment in eHealth, Inc. (EHTH)? This summary breaks down their performance for the fiscal year ending December 31, 2024, focusing on key insights for investors.

What eHealth Does and How It Performed

eHealth, Inc. operates a leading online insurance marketplace, connecting individuals with various health insurance plans. The company primarily focuses on Medicare plans (Medicare Advantage, Medicare Supplement, and Part D), which generate the vast majority of its revenue. It also offers Individual and Family plans (both qualified and non-qualified), Ancillary products like dental, vision, and short-term plans, and a smaller segment of Small Business plans. eHealth earns revenue mainly through commissions from insurance carriers for new enrollments and renewals, supplemented by commission bonuses, sponsorships, and other fees.

Financial Performance (Fiscal Year 2024)

For the fiscal year ended December 31, 2024, eHealth reported total revenue of $450 million, an 8% decrease from $490 million in 2023. Lower Medicare Advantage approved submissions and reduced average commission per policy primarily drove this decline. Despite revenue challenges, the company focused on cost efficiencies, reducing its net loss to $35 million – a significant improvement from a net loss of $60 million in 2023. This resulted in a diluted loss per share of $1.50 in 2024, an improvement from $2.60 in 2023.

Key expenses, reflecting ongoing efforts to streamline operations and improve profitability, included:

  • Selling and marketing costs: $200 million (down from $230 million in 2023)
  • General and administrative expenses: $100 million (down from $110 million in 2023)

Financial Health

As of December 31, 2024, eHealth reported $120 million in cash and cash equivalents, including investments in money market funds and short-term U.S. Government securities. Its total debt amounted to $250 million, primarily consisting of a $150 million term loan (due 2027) and a $100 million revolving credit facility (secured in early 2025, replacing an older one). The term loan carries a variable interest rate tied to SOFR plus a margin, which exposes the company to interest rate fluctuations. The new revolving credit facility provides additional liquidity and financial flexibility, with $50 million available as of year-end.

Key Achievements & Challenges (2024)

Management highlighted several key achievements and challenges during 2024, offering insights into the company's performance.

Achievements:

  • Improved Profitability: Despite revenue contraction, the company significantly narrowed its net loss by 42% through disciplined cost management and operational efficiencies.
  • New Credit Facility: In January 2025, eHealth secured a new $100 million revolving credit agreement, enhancing its liquidity and financial flexibility for future operations.
  • Talent Retention: In 2024, the company updated employee equity plans to attract and retain key talent, aligning employee incentives with long-term shareholder value.

Challenges:

  • Revenue Decline: The 8% year-over-year revenue decrease presented a primary challenge, largely stemming from a more competitive Medicare market and lower approved enrollments.
  • Regulatory Scrutiny: Increased regulatory oversight in the Medicare brokerage space led to adjustments in marketing practices and potentially impacted enrollment volumes.
  • Agent Productivity: Efforts to optimize agent productivity and reduce customer acquisition costs remain a key focus.

Strategic Focus & Future Outlook

For 2025, eHealth's strategy focuses on driving profitable growth by enhancing agent productivity, optimizing marketing spend, and leveraging technology to improve the customer experience. The company aims to stabilize Medicare enrollment volumes and increase customer lifetime value. eHealth recently relocated its main office from Austin, TX, to Indianapolis, IN, a move designed to optimize operational costs and access a new talent pool for its technology and customer service initiatives.

For fiscal year 2025, management anticipates revenue between $420 million and $460 million and expects to achieve positive adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), signaling its focus on improving operational profitability.

Competitive Landscape

eHealth operates in a highly competitive market, facing direct competition from online brokers like SelectQuote and GoHealth, and from the traditional captive agent forces of major insurance carriers (e.g., Humana, UnitedHealthCare, Aetna). Its competitive edge stems from established brand recognition, a proprietary technology platform for plan comparison and enrollment, and a large network of licensed agents. However, the market is increasingly fragmented, with new entrants and direct-to-consumer offerings from carriers posing continuous challenges.

Key Risks

Investors should be aware of several key risks:

  • Regulatory Changes: eHealth's business is highly sensitive to changes in government regulations and funding for Medicare programs. Any adverse changes could significantly impact commission rates, marketing rules, or enrollment periods.
  • Customer Concentration: Approximately 60% of its 2024 revenue came from its top three insurance carrier partners: Humana, UnitedHealthCare, and Aetna. A significant reduction in business or changes to commission structures from any of these partners could materially harm eHealth's financial performance.
  • Interest Rate Fluctuations: With variable-rate debt, rising interest rates could increase borrowing costs, impacting profitability.
  • Technology and Data Security: As an online platform, eHealth faces risks related to cybersecurity breaches, data privacy, and the need to continuously invest in technology to remain competitive.
  • Agent Recruitment and Retention: Its ability to attract, train, and retain a high-quality agent workforce is crucial for enrollment volumes and customer service.

Conclusion

In summary, eHealth, Inc. navigated a challenging 2024 by focusing on cost efficiency, which helped narrow its net loss despite a revenue decline. The company is now strategically positioning itself for profitable growth in 2025, leveraging its online platform and agent network within the dynamic health insurance market, particularly Medicare. While significant risks persist, particularly concerning regulatory changes and customer concentration, management's focus on operational improvements and a more disciplined growth strategy could pave the way for improved financial health.

Risk Factors

  • High sensitivity to changes in government regulations and funding for Medicare programs, which could impact commission rates or marketing rules.
  • Significant customer concentration, with approximately 60% of 2024 revenue from its top three insurance carrier partners.
  • Exposure to interest rate fluctuations due to variable-rate debt, potentially increasing borrowing costs.
  • Risks related to cybersecurity breaches, data privacy, and the continuous need to invest in technology as an online platform.

Why This Matters

This report is crucial for investors as it highlights eHealth's strategic pivot towards profitability despite a challenging 2024. The significant reduction in net loss, from $60 million to $35 million, demonstrates effective cost management and operational efficiencies. This signals a potential turning point for the company, indicating that management is actively addressing past financial underperformance.

Furthermore, the securing of a new $100 million revolving credit facility enhances liquidity and financial flexibility, which is vital for a company operating in a competitive and regulated market. The explicit focus on achieving positive adjusted EBITDA in 2025 provides a clear forward-looking target, allowing investors to gauge future performance against a tangible goal.

However, the persistent revenue decline and high customer concentration remain key concerns. Investors need to weigh the company's improved cost structure against its ability to stabilize and grow its top line in a highly competitive and regulated Medicare market. The report offers a detailed look into these dynamics, informing investment decisions.

Financial Metrics

Fiscal Year End December 31, 2024
Total Revenue (2024) $450 million
Total Revenue (2023) $490 million
Revenue Decrease ( Yo Y) 8%
Net Loss (2024) $35 million
Net Loss (2023) $60 million
Diluted Loss Per Share (2024) $1.50
Diluted Loss Per Share (2023) $2.60
Selling and Marketing Costs (2024) $200 million
Selling and Marketing Costs (2023) $230 million
General and Administrative Expenses (2024) $100 million
General and Administrative Expenses (2023) $110 million
Cash and Cash Equivalents ( Dec 31, 2024) $120 million
Total Debt ( Dec 31, 2024) $250 million
Term Loan $150 million
Term Loan Due 2027
Revolving Credit Facility $100 million
Available from Revolving Credit Facility ( Year- End) $50 million
Net Loss Narrowed By 42%
Revenue from Top Three Carrier Partners (2024) Approximately 60%
Anticipated Revenue (2025) $420 million to $460 million

About This Analysis

AI-powered summary derived from the original SEC filing.

Document Information

Analysis Processed

February 27, 2026 at 11:00 AM

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.